JPH10503525A - カンプトテシン誘導体及びその製造方法 - Google Patents
カンプトテシン誘導体及びその製造方法Info
- Publication number
- JPH10503525A JPH10503525A JP8521569A JP52156996A JPH10503525A JP H10503525 A JPH10503525 A JP H10503525A JP 8521569 A JP8521569 A JP 8521569A JP 52156996 A JP52156996 A JP 52156996A JP H10503525 A JPH10503525 A JP H10503525A
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- compound
- mmol
- camptothecin
- dichloromethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.下記一般式(I)で示されるカンプトテシン誘導体及び薬剤学的に許容され るその塩: 前記式で、Rは水素或いは-(CH2)2-NR1R2(R1は水素或いは一般的なアミノ保護基 を示し、R2は低級アルキル基、ヒドロキシエチル、或いはアセトキシエチルを示 し、またR2は隣接した窒素と結合してヘテロ環化合物を形成することができる) を示し; n=1或いは2であり; (R7はメチル、エチル、またはCH3OCH2CH2-を示す)を示す]であり; 前記式で、 n=2であり、R4が水素である場合には、Rは水素ではなく; また、n=2、R3が水素である場合には、Rは水素ではなく; また、Rが-CH2CH2NHCH3である場合には、R3は水素ではない。 2.下記一般式(II)で示されるカンプトテシン合成中間体: 前記式で、R’は−(CH2)2-NR1R2(R1は一般的なアミノ保護基を示し、R2 は低級アルキル基、ヒドロキシエチル、或いはアセトキシエチルを示し、R2は 隣接した窒素と結合してヘテロ環化合物を形成することができる)を示す。 3.下記一般式(III)で示されるカンプトテシン合成中間体: 前記式で、 l) ;CH2OR7(R7=メチル、エチル、または-CH2OCH2CH3)]であり; 前記式で、 n=2であり、R4が水素である場合には、Rは水素ではなく; また、n=2、R3が水素である場合には、Rは水素ではなく; また、Rが-CH2CH2NHCH3である場合には、R3は水素ではない。 4.下記一般式(II)の化合物を、下記一般式(III)の化合物と酸性条件下で 反応させる段階を含む下記一般式(I)化合物の製造方法 前記式で、 Rは水素或いは-(CH2)2-NR1R2(R1は水素或いは一般的なアミノ保護基を 示し、R2は低級アルキル基、ヒドロキシエチル、或いはアセトキシエチルを示し 、また、R2は隣接した窒素と結合してヘテロ環化合物を形成することができる) を示し; R'は水素或いは-(CH2)2-NR1R2であり、R1は一般的なアミノ保護基を示 し、R2は低級アルキル基、ヒドロキシエチル、或いはアセトキシエチルであり、 また、R2は隣接した窒素と結合してヘテロ環化合物を形成することができる; n=1、或いは2であり; R6(R6はイソプロピル、フェニル、-CH2CH2Clを示す);CH2OR7(R7はメチル、エ チル、CH3OCH2CH2-を示す)を示す]であり; 前記式で、 n=2であり、R4が水素である場合には、Rは水素ではなく; また、n=2、R3が水素である場合には、Rは水素ではなく; また、Rが-CH2CH2NHCH3である場合には、R3は水素ではない。 5.下記一般式(I)で示されるカンプトテシン誘導体及び薬剤学的に許容され るその塩を含有する抗癌剤: 前記式で、 Rは水素或いは-(CH2)2-NR1R2、(R1は水素、或いは一般的なアミノ保護 基を示し、R2は低級アルキル基、ヒドロキシエチル、或いはアセトキシエチルを 示し、また、R2は隣接した窒素と結合してヘテロ環化合物を形成することができ る)を示し; n=1、或いは2であり; CH2OR7(R7はメチル、エチル、CH3OCH2CH2-を示す)を示す]であり; 前記式で、 n=2であり、R4が水素である場合には、Rは水素ではなく; また、n=2、R3が水素である場合には、Rは水素ではなく; また、Rが -CH2CH2NHCH3である場合には、R3は水素ではない。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1995/269 | 1995-01-09 | ||
KR1019950000269A KR960029336A (ko) | 1995-01-09 | 1995-01-09 | 캄토테신 유도체, 그의 제조 방법 및 이를 함유하는 항암제 |
PCT/KR1996/000004 WO1996021666A1 (en) | 1995-01-09 | 1996-01-09 | Camptothecin derivatives and its manufacturing method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH10503525A true JPH10503525A (ja) | 1998-03-31 |
JP3023990B2 JP3023990B2 (ja) | 2000-03-21 |
Family
ID=19406538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8521569A Expired - Lifetime JP3023990B2 (ja) | 1995-01-09 | 1996-01-09 | カンプトテシン誘導体及びその製造方法 |
Country Status (9)
Country | Link |
---|---|
US (2) | US6265413B1 (ja) |
EP (1) | EP0802915B1 (ja) |
JP (1) | JP3023990B2 (ja) |
KR (2) | KR960029336A (ja) |
CN (1) | CN1077575C (ja) |
AU (1) | AU4400696A (ja) |
CA (1) | CA2208639C (ja) |
DE (1) | DE69625176T2 (ja) |
WO (1) | WO1996021666A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007514779A (ja) * | 2003-12-17 | 2007-06-07 | バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド | カンプトテシン誘導体の製造方法 |
JP2008273952A (ja) * | 2001-02-21 | 2008-11-13 | Yakult Honsha Co Ltd | カンプトテシン関連化合物の合成方法 |
WO2016027757A1 (ja) * | 2014-08-18 | 2016-02-25 | 国立大学法人大阪大学 | 新規2-アミノベンゾイル誘導体 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997001539A1 (en) * | 1995-06-27 | 1997-01-16 | Takeda Chemical Industries, Ltd. | 4-acylamino(halogeno) alkyl-quinoline derivatives, their preparation and their use as melatonin agonists |
SG88737A1 (en) * | 1996-10-30 | 2002-05-21 | Tanabe Seiyaku Co | S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
IN189180B (ja) * | 1997-07-09 | 2003-01-04 | Chong Kun Dang Corp | |
US6352996B1 (en) * | 1999-08-03 | 2002-03-05 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
EP1433789A1 (en) * | 2002-12-24 | 2004-06-30 | Aponetics AG | Pyrrolopyrazines and their use as selective apoptosis inducers |
ITMI20061475A1 (it) * | 2006-07-26 | 2008-01-27 | Indena Spa | Derivati della camptotecina ad attivita antitumorale |
CN101824038B (zh) * | 2009-03-06 | 2013-08-21 | 复旦大学 | 喜树碱及其类似物的制备方法 |
CN107428770B (zh) | 2014-10-22 | 2019-10-01 | 维瓦西塔斯肿瘤学公司 | 用于喜树碱类似物合成的方法和体系 |
CN113286796A (zh) * | 2019-01-30 | 2021-08-20 | 四川科伦博泰生物医药股份有限公司 | 喜树碱衍生物及其水溶性前药、包含其的药物组合物及其制备方法和用途 |
WO2022217022A1 (en) | 2021-04-10 | 2022-10-13 | Profoundbio Us Co. | Folr1 binding agents, conjugates thereof and methods of using the same |
TW202308699A (zh) | 2021-04-23 | 2023-03-01 | 美商普方生物製藥美國公司 | Cd70結合劑、其結合物及其使用方法 |
TW202320857A (zh) | 2021-07-06 | 2023-06-01 | 美商普方生物製藥美國公司 | 連接子、藥物連接子及其結合物及其使用方法 |
CN116253741B (zh) * | 2022-12-30 | 2024-02-02 | 上海禧耀医药科技有限公司 | 一种贝洛替康衍生物的合成方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5198300A (en) * | 1975-02-20 | 1976-08-30 | Kanputoteshin oyobi sonoruijitaino seizoho | |
JPS5839685A (ja) * | 1981-09-04 | 1983-03-08 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体及びその製造法 |
JPS58154582A (ja) | 1982-03-10 | 1983-09-14 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体およびその製造法 |
US4894456A (en) | 1987-03-31 | 1990-01-16 | Research Triangle Institute | Synthesis of camptothecin and analogs thereof |
EP0547165B1 (en) * | 1990-09-28 | 1999-11-10 | Smithkline Beecham Corporation | Process for the Preparation of Water-Soluble Camptothecin Analogues, as well as the compounds 10-Hydroxy-11-C(1-6)-alkoxycamptothecin |
EP0540099B1 (en) | 1991-10-29 | 1996-04-17 | Glaxo Wellcome Inc. | Water soluble camptothecin derivatives |
US5391745A (en) * | 1992-07-23 | 1995-02-21 | Sloan-Kettering Institute For Cancer Research | Methods of preparation of camptothecin analogs |
-
1995
- 1995-01-09 KR KR1019950000269A patent/KR960029336A/ko unknown
-
1996
- 1996-01-09 AU AU44006/96A patent/AU4400696A/en not_active Abandoned
- 1996-01-09 WO PCT/KR1996/000004 patent/WO1996021666A1/en active IP Right Grant
- 1996-01-09 CN CN96191392A patent/CN1077575C/zh not_active Expired - Lifetime
- 1996-01-09 US US08/860,655 patent/US6265413B1/en not_active Expired - Lifetime
- 1996-01-09 JP JP8521569A patent/JP3023990B2/ja not_active Expired - Lifetime
- 1996-01-09 DE DE69625176T patent/DE69625176T2/de not_active Expired - Lifetime
- 1996-01-09 CA CA002208639A patent/CA2208639C/en not_active Expired - Lifetime
- 1996-01-09 EP EP96900458A patent/EP0802915B1/en not_active Expired - Lifetime
- 1996-01-09 KR KR1019960000248A patent/KR0163267B1/ko active IP Right Grant
-
1999
- 1999-03-26 US US09/277,178 patent/US6177568B1/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008273952A (ja) * | 2001-02-21 | 2008-11-13 | Yakult Honsha Co Ltd | カンプトテシン関連化合物の合成方法 |
JP2007514779A (ja) * | 2003-12-17 | 2007-06-07 | バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド | カンプトテシン誘導体の製造方法 |
JP4701185B2 (ja) * | 2003-12-17 | 2011-06-15 | バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド | カンプトテシン誘導体の製造方法 |
WO2016027757A1 (ja) * | 2014-08-18 | 2016-02-25 | 国立大学法人大阪大学 | 新規2-アミノベンゾイル誘導体 |
JPWO2016027757A1 (ja) * | 2014-08-18 | 2017-07-20 | 国立大学法人大阪大学 | 新規2−アミノベンゾイル誘導体 |
Also Published As
Publication number | Publication date |
---|---|
US6265413B1 (en) | 2001-07-24 |
CN1077575C (zh) | 2002-01-09 |
WO1996021666A1 (en) | 1996-07-18 |
KR960029336A (ko) | 1996-08-17 |
CA2208639C (en) | 2001-07-31 |
DE69625176T2 (de) | 2003-07-10 |
KR0163267B1 (ko) | 1998-12-01 |
DE69625176D1 (de) | 2003-01-16 |
CN1168139A (zh) | 1997-12-17 |
JP3023990B2 (ja) | 2000-03-21 |
US6177568B1 (en) | 2001-01-23 |
CA2208639A1 (en) | 1996-07-18 |
EP0802915A1 (en) | 1997-10-29 |
EP0802915B1 (en) | 2002-12-04 |
AU4400696A (en) | 1996-07-31 |
KR960029337A (ko) | 1996-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU652728B2 (en) | Camptothecin analogs as potent inhibitors of human colorectal cancer | |
US5004758A (en) | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells | |
US4981968A (en) | Synthesis of camptothecin and analogs thereof | |
US5122526A (en) | Camptothecin and analogs thereof and pharmaceutical compositions and method using them | |
US4894456A (en) | Synthesis of camptothecin and analogs thereof | |
US5180722A (en) | 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs | |
JPH10503525A (ja) | カンプトテシン誘導体及びその製造方法 | |
US5364858A (en) | Camptothecin analogs as potent inhibitors of topoisomerase I | |
JP3545416B2 (ja) | フペルジンa誘導体、その製造およびその使用 | |
US5340817A (en) | Method of treating tumors with anti-tumor effective camptothecin compounds | |
JPH08503221A (ja) | 水溶性カンプトテシン誘導体 | |
US5227380A (en) | Pharmaceutical compositions and methods employing camptothecins | |
RU2450007C2 (ru) | Производные камптотецина с противоопухолевой активностью | |
KR100570254B1 (ko) | 광학적으로 순수한 캄프토테신 동족체, 광학적으로 순수한합성 중간체 및 그들의 제조 방법 | |
JPH08509740A (ja) | カンプトテシンの水溶性誘導体 | |
EP1638978B1 (en) | 7-substituted camptothecin and camptothecin analogs and methods for preparing same | |
AU2002300268B2 (en) | New benzo[b]pyrano[3,2-h]acridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them | |
JPH11501679A (ja) | 20(s)−カンプトテシンの新規な水溶性c−環類似体 | |
EP2096113A1 (en) | 9-substituted camptothecin derivatives as antitumor compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080121 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090121 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090121 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100121 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110121 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110121 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120121 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120121 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130121 Year of fee payment: 13 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |